logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Wenqi Zhou

Chongqing University Cancer Hospital
H指数:6
被引数:119

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathological response and metabolites’ prognostic role in HER2-positive breast cancer treated with neoadjuvant pyrotinib, trastuzumab, nab-paclitaxel, and carboplatin: a single-arm phase II trial

病理反应和代谢物的预后作用：在HER2阳性乳腺癌患者中接受新辅助吡咯替尼、曲妥珠单抗、白蛋白结合型紫杉醇和卡铂治疗的单臂II期试验

Breast Cancer Research
IF5.6
2025-10-300
OAAI
Mei Liu; La Zou; Ningning Zhang; Wenqi Zhou; Xianjun Pan; Yongchun Deng; Yeli Yue; Jing Wu; Xinrui Liang; Maoshan Chen; Xiaohua Zeng
A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2-Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

一项Fulvestrant联合新辅助化疗治疗ER+/HER2-局部晚期乳腺癌的单臂II期临床试验：治疗反应与18F-FES PET-CT及代谢物的综合分析

CANCER RESEARCH AND TREATMENT
IF3.8
2025-01-150
OA
Shao, Qing; Zhang, Ningning; Pan, Xianjun; Zhou, Wenqi; Wang, Yali; Chen, Xiaoliang; Wu, Jing; Zeng, Xiaohua

研究方向

暂未获取到该数据
X
Xianjun Pan
H 指数:3论文数:15被引数:42
J
Junjie Zeng
H 指数:9论文数:43被引数:244
X
Xiaohua Zeng
H 指数:9论文数:50被引数:260
X
Xiaohua Zeng
H 指数:9论文数:77被引数:464
Q
Qing Shao
H 指数:24论文数:163被引数:2,434
Y
Yu Feng
H 指数:33论文数:215被引数:3,489
G
Guangyu Yao
H 指数:22论文数:93被引数:1,788
胡小蕾 封面图
胡小蕾
H 指数:29论文数:173被引数:2,725
L
Lujia Chen
H 指数:16论文数:48被引数:1,231
N
Ningning Zhang
H 指数:18论文数:152被引数:1,248